☰

Xiaowei Dong, Ph.D. - Publications

Affiliations: 
2009 University of Kentucky, Lexington, KY 
Area:
Pharmaceutical Chemistry, Medicine and Surgery, Oncology
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tanaudommongkon I, Tanaudommongkon A, Prathipati P, Nguyen JT, Keller ET, Dong X. Curcumin Nanoparticles and Their Cytotoxicity in Docetaxel-Resistant Castration-Resistant Prostate Cancer Cells. Biomedicines. 8. PMID 32751450 DOI: 10.3390/Biomedicines8080253  0.413
2017 Zhu J, Dong X. Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation. Journal of Visualized Experiments : Jove. PMID 28570541 DOI: 10.3791/55584  0.375
2017 Tanaudommongkon A, Tanaudommongkon I, Prathipati P, Nguyen J, Dong X. Development and Characterization of Docetaxel-Loaded Nanoparticles for Docetaxel-Resistant Castration-Resistant Prostate Cancer Journal of Nanoscience and Nanotechnology. 17: 3920-3926. DOI: 10.1166/Jnn.2017.13089  0.342
2016 Prathipati P, Zhu J, Dong X. Development of novel HDL-mimicking α-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 27531623 DOI: 10.1016/J.Ejpb.2016.08.005  0.361
2016 Guo S, Pham K, Li D, Penzak SR, Dong X. Novel in situ self-assembly nanoparticles for formulating a poorly water-soluble drug in oral solid granules, improving stability, palatability, and bioavailability. International Journal of Nanomedicine. 11: 1451-60. PMID 27103803 DOI: 10.2147/Ijn.S100621  0.334
2016 Pham K, Li D, Guo S, Penzak S, Dong X. Development and in vivo evaluation of child-friendly lopinavir/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26849919 DOI: 10.1016/J.Jconrel.2016.02.001  0.328
2010 Dong X, Mumper RJ. Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine (London, England). 5: 597-615. PMID 20528455 DOI: 10.2217/Nnm.10.35  0.567
2009 Ma P, Dong X, Swadley CL, Gupte A, Leggas M, Ledebur HC, Mumper RJ. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. Journal of Biomedical Nanotechnology. 5: 151-61. PMID 20055093 DOI: 10.1166/Jbn.2009.1021  0.6
2009 Dong X, Mattingly CA, Tseng MT, Cho MJ, Liu Y, Adams VR, Mumper RJ. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. Cancer Research. 69: 3918-26. PMID 19383919 DOI: 10.1158/0008-5472.Can-08-2747  0.592
2009 Dong X, Mattingly CA, Tseng M, Cho M, Adams VR, Mumper RJ. Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization European Journal of Pharmaceutics and Biopharmaceutics. 72: 9-17. PMID 19111929 DOI: 10.1016/J.Ejpb.2008.11.012  0.591
2006 Dong X, Mumper RJ. The metabolism of fatty alcohols in lipid nanoparticles by alcohol dehydrogenase. Drug Development and Industrial Pharmacy. 32: 973-80. PMID 16954110 DOI: 10.1080/03639040600640006  0.532
Show low-probability matches.